Author(s): Manu Mehta, Sarika Gupta, Ajay Duseja

Email(s): sarika.ashish@gmail.com , manumehta1298@gmail.com , ajayduseja@yahoo.co.in

DOI: 10.52711/0974-360X.2021.00814   

Address: Manu Mehta1, Sarika Gupta2, Ajay Duseja3
1Pursuing PhD, Department of Bioscience Biotechnology, Banasthali Vidyapith, Jaipur, India.
2Department of Biosciences and Biotechnology, Banasthali Vidyapith, Jaipur, India.
3Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 9,     Year - 2021


ABSTRACT:
Background and AIM: Potential utilization of medicine from herbal origin is on the rise due to adverse effects of allopathic medicines. Phyllanthin extracted from Phyllanthus niruri has been shown to be effective in Hepatoprotective effect. Its therapeutic effect in non-alcoholic fatty liver disease (NAFLD) is not much explored. The present study aim was to evaluate the role of phyllanthin in mice fed with methionine choline deficient (MCD) diet. Materials and Methods: Four–five week-old C57lb/6 mice were fed MCD diet for 4 weeks to develop experimental model of NAFLD in small animal research laboratory, PGIMER, Chandigarh. Phyllanthin extract and commercially available phyllanthin was used to assess the impact on NAFLD animal model. After recovery animal weight, liver function test, and lipid profile were measured. Data were showed as mean and standard deviation. Statistical analysis was executing using SPSS v21. Results: Data revealed that administration of 200mg/kg and 400mg/kg crude extract significantly reduced (P<0.0001) bilirubin levels in MCDD mice (0.69±0.14 and 0.85±0.14) respectively. Administration of 400mg/kg phyllanthin significantly reduced SGOT in MCDD mice (23.3±11.87 vs. 50.17±7.68; P=0.002). Administration of 200mg/kg and 400 mg/kg crude extract significantly reduced SGPT in MCDD mice (29.4±14.39 and 21.80±6.12 respectively) (P<0.0001). Similarly, plant phyllanthin improved lipid profile in MCD animals. The plant phyllanthin does not have adverse effect on body weight. Conclusion: Out of the two test trails as plant phyllanthin and commercial phyllanthin, the former suggested hepatoprotective action, as it causes the reversal of damage in the hepatic profile due to NAFLD.


Cite this article:
Manu Mehta, Sarika Gupta, Ajay Duseja. Evaluation of Hepatoprotective effect of Phyllanthus niruri in experimental model of NAFLD. Research Journal of Pharmacy and Technology. 2021; 14(9):4685-0. doi: 10.52711/0974-360X.2021.00814

Cite(Electronic):
Manu Mehta, Sarika Gupta, Ajay Duseja. Evaluation of Hepatoprotective effect of Phyllanthus niruri in experimental model of NAFLD. Research Journal of Pharmacy and Technology. 2021; 14(9):4685-0. doi: 10.52711/0974-360X.2021.00814   Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-9-28


REFERENCES:
1.    Duseja A. Nonalcoholic fatty liver disease in India – a lot done, yet more required! Indian J Gastroenterol. 2010; 29: 217–225
2.    Iqbal U, Perumpail BJ, Akhtar D, Kim D, Ahmed A. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. Medicines. 2019; 6: 41.
3.    Yang JD, Abdelmalek MF, Pang H, Guy CD, Smith AD, Diehl AM et al. Gender and Menopause Impact Severity of Fibrosis Among Patients with Nonalcoholic Steatohepatitis. Hepatology 2014, 59, 1406-1414.
4.    Yao, Yu-Jie Qiao, Ya-Li Zhao, Xu-Feng Tao et.al. Herbal medicines and nonalcoholic fatty liver disease. Hong World J Gastroenterol 2016; 30: 6890-6905
5.    Khanna AK, Rizvi F, Chander R. Lipid lowering activity of Phyllanthus niruri in hyperlipemic mice. J Ethnopharmacol. 2002; 82: 19-22
6.    Pearlman FC, Lee RT. Detection and measurement of total bilirubin in serum, with use of surfactants as solubilizing agents. Clin Chem. 1974; 20: 447-53
7.    Thomas L. Alanine aminotransferase (ALT), Aspartate aminotransferase (AST). In: Thomas L, editor. Clinical Laboratory Diagnostics. 1st ed. Frankfurt: TH-Books Verlagsgesellschaft; 1998. p. 55-65
8.    Bradley DW, Maynard JE, Emery G, Webster H. Transaminase activities in serum of long-term hemodialysis patients. Clin Chem. 1972; 18: 1442
9.    Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974; 20: 470-5
10.    Rifai N, Bachorik PS, Alberts JJ. Lipids, lipoproteins and apolipoproteins. In: Burtis CA, Ashwood ER, editors Tietz Textbook of Clinical Chemistry. 3rd ed. Philadelphia: W. Saunders Company; 1999. p. 809-61
11.    Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970; 11: 583-95.
12.    Townsend SA, Newsome PN. Non-alcoholic fatty liver disease in 2016. Br Med Bull. 2016; 119: 143–156
13.    Ong, H., and Norzalina, J. Malay herbal medicine in Gemencheh, Negri Sembilan, Malaysia. Fitoterapia. 1999; 70: 10-14.
14.    C.O. Okoli, I.C. Obidike, A.C. Ezike , P.A. Akah, and O.A. Salawu. Studies on the possible mechanisms of antidiabetic activity of extract of aerial parts of Phyllanthus niruri. Pharmaceutical Biology, 2011; 49: 248-255.
15.    Kim S-B, Kang O-H, Lee Y-S, Han S-H, Ahn Y-S, Cha S-W, et al. Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. PLoS ONE 2016; 11: e0147745
16.    Van Herck MA, Vonghia L, Francque SM. Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide. Nutrients. 2017; 9: 1072.
17.    Al Zarzour RH, Ahmad M, Asmawi MZ, et al. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Mice. Nutrients. 2017; 9: 766.
18.    Zahra AA, Mehmet B, Alshawsh MA, Ali HM, Hadi HA, Abdulla MA. Protective Role of Phyllanthus niruri Extract against Thioacetamide-Induced Liver Cirrhosis in Rat Model. Evidence-Based Complementary and Alternative Medicine. 2012: Article ID 241583.
19.    Blumberg BS, Millman I, Venkateswaran PS, Thyagarajan SP. Hepatitis B Virus and hepatocellular carcinoma-treatment of HBV carriers with Phyllanthus amarus. Cancer Detect Prevent. 1989; 1.
20.    Manjrekar AP, Jisha V, Bag PP, Adhikary B, Pai MM , Hegde A et al. Effect of Phyllanthus niruri Linn. Treatment on liver, kidney and testes in CCl4 induced hepatotoxic mice. Indian Journal of Experimental Biology. 2008; 46: 514-520

Recomonded Articles:

Author(s): Nimbalkar V.V., Pansare P.M., Nishane B.B.

DOI: 10.5958/0974-360X.2015.00310.8         Access: Open Access Read More

Author(s): Trophimus Gnanabagyan Jayakaran, Vignesh R, Shankar P

DOI: 10.5958/0974-360X.2019.00700.5         Access: Open Access Read More

Author(s): Vijayalakshmi. S , Disalva. X, Chittaranjan Srivastava, Arun A

DOI: 10.5958/0974-360X.2019.00520.1         Access: Open Access Read More

Author(s): Hayat M. Mukhtar, Vandna Kalsi

DOI: 10.5958/0974-360X.2018.00395.5         Access: Open Access Read More

Author(s): Pande S. D., Wagh A.S., Bhagure L.B., Patil S.G., Deshmukh A.R.

DOI: 10.5958/0974-360X.2015.00070.0         Access: Open Access Read More

Author(s): Vandana Devi Sahu, Mukta Agrawal, Mukesh Sharma, Sandhya Chandrakar, Sujata Gupta, Garima Sharma, Kalyani Dewangan, Harsha Solanki, Manisha Majumdar, D. K. Tripathi, Amit Alexander, Ajazuddin

DOI: 10.5958/0974-360X.2016.00145.1         Access: Open Access Read More

Author(s): Muhammad Hamdan, Noorhamdani AS, Masruroh Rahayu, Mohammmad Hasan Machfoed

DOI: 10.5958/0974-360X.2019.01020.5         Access: Open Access Read More

Author(s): Loveleen Preet Kaur, Rajeev Garg, GD Gupta

DOI: Not Available         Access: Open Access Read More

Author(s): Vaseeha Banu T.S., Sandhya K.V., K.N. Jayaveera

DOI: Not Available         Access: Open Access Read More

Author(s): Yasmin A, Vijaya Bharathi R, Radha R

DOI: 10.5958/0974-360X.2019.00429.3         Access: Open Access Read More

Author(s): M. Sumithra, Avantika Prabhabanik

DOI: 10.5958/0974-360X.2017.00036.1         Access: Open Access Read More

Author(s): Raj Kumar R, Praveen D, Palani Shanmugasundaram

DOI: 10.5958/0974-360X.2016.00164.5         Access: Open Access Read More

Author(s): V Rajesh Babu, Syeda Rana Nikhat, P Nivethithai, SH Areefulla

DOI: Not Available         Access: Open Access Read More

Author(s): H.B. Pagar, U.P. Shinde, Y.S. Agrawal, S.D. Barhate, T.S. Luhade, R.O. Sonawane

DOI: Not Available         Access: Open Access Read More

Author(s): A. Rajendra Kumar, N. J. Muthukumar, A. Faridha

DOI: 10.5958/0974-360X.2019.00081.7         Access: Open Access Read More

Author(s): Harsha Vardhani Kondepati, Girish Pai Kulyadi, Vamshi Krishna Tippavajhala

DOI: 10.5958/0974-360X.2018.00069.0         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags